301
Participants
Start Date
October 31, 2014
Primary Completion Date
April 21, 2017
Study Completion Date
May 7, 2018
somapacitan
Administered subcutaneously (s.c., under the skin) once weekly for 26 weeks following 8 weeks of titration. Extension of 44 weeks' treatment following 8 weeks of titration.
somatropin
Administered subcutaneously (s.c., under the skin) once daily for 26 weeks following 8 weeks of titration. Re-randomisation to extension of 44 weeks' treatment following 8 weeks of titration.
placebo
Administered subcutaneously (s.c., under the skin) once weekly for 26 weeks following 8 weeks of titration.
Novo Nordisk Investigational Site, Darlinghurst
Novo Nordisk Investigational Site, Johannesburg
Novo Nordisk Investigational Site, St Leonards
Novo Nordisk Investigational Site, Blacktown
Novo Nordisk Investigational Site, Johannesburg
Novo Nordisk Investigational Site, Coffs Harbour
Novo Nordisk Investigational Site, Parkville
Novo Nordisk Investigational Site, Box Hill
Novo Nordisk Investigational Site, Woolloongabba
Novo Nordisk Investigational Site, Nedlands
Novo Nordisk Investigational Site, Tygerberg
Novo Nordisk Investigational Site, New York
Novo Nordisk Investigational Site, Berlin
Novo Nordisk Investigational Site, Pulau Pinang
Novo Nordisk Investigational Site, Berlin
Novo Nordisk Investigational Site, Pittsburgh
Novo Nordisk Investigational Site, Philadelphia
Novo Nordisk Investigational Site, Philadelphia
Novo Nordisk Investigational Site, Baltimore
Novo Nordisk Investigational Site, Oldenburg
Novo Nordisk Investigational Site, Roswell
Novo Nordisk Investigational Site, Atlanta
Novo Nordisk Investigational Site, Istanbul
Novo Nordisk Investigational Site, Istanbul
Novo Nordisk Investigational Site, Izmir
Novo Nordisk Investigational Site, Birmingham
Novo Nordisk Investigational Site, Kocaeli
Novo Nordisk Investigational Site, Cleveland
Novo Nordisk Investigational Site, East Lansing
Novo Nordisk Investigational Site, Petah Tikva
Novo Nordisk Investigational Site, Kaunas
Novo Nordisk Investigational Site, Aachen
Novo Nordisk Investigational Site, Tel Litwinsky
Novo Nordisk Investigational Site, Frankfurt
Novo Nordisk Investigational Site, Putrajaya
Novo Nordisk Investigational Site, St Louis
Novo Nordisk Investigational Site, Tel Aviv
Novo Nordisk Investigational Site, Topeka
Novo Nordisk Investigational Site, Omaha
Novo Nordisk Investigational Site, Plano
Novo Nordisk Investigational Site, Houston
Novo Nordisk Investigational Site, San Antonio
Novo Nordisk Investigational Site, Shavano Park
Novo Nordisk Investigational Site, El Paso
Novo Nordisk Investigational Site, Aurora
Novo Nordisk Investigational Site, Salt Lake City
Novo Nordisk Investigational Site, Las Vegas
Novo Nordisk Investigational Site, Reno
Novo Nordisk Investigational Site, Los Angeles
Novo Nordisk Investigational Site, Los Angeles
Novo Nordisk Investigational Site, Kuching
Novo Nordisk Investigational Site, Portland
Novo Nordisk Investigational Site, Federal Way
Novo Nordisk Investigational Site, New Dehli
Novo Nordisk Investigational Site, Moscow
Novo Nordisk Investigational Site, Moscow
Novo Nordisk Investigational Site, Chandigarh
Novo Nordisk Investigational Site, Timișoara
Novo Nordisk Investigational Site, Mumbai
Novo Nordisk Investigational Site, Cluj-Napoca
Novo Nordisk Investigational Site, Kazan'
Novo Nordisk Investigational Site, Hyderabad
Novo Nordisk Investigational Site, Hyderabad
Novo Nordisk Investigational Site, Târgu Mureş
Novo Nordisk Investigational Site, Sibiu
Novo Nordisk Investigational Site, Bangalore
Novo Nordisk Investigational Site, Novosibirsk
Novo Nordisk Investigational Site, Tomsk
Novo Nordisk Investigational Site, Krasnoyarsk
Novo Nordisk Investigational Site, Kochi
Novo Nordisk Investigational Site, Kolkata
Novo Nordisk Investigational Site, Iași
Novo Nordisk Investigational Site, Boston
Novo Nordisk Investigational Site, Omaha
Novo Nordisk Investigational Site, Seattle
Novo Nordisk Investigational Site, São Paulo
Novo Nordisk Investigational Site, Bunkyo-ku, Tokyo
Novo Nordisk Investigational Site, Chiba-shi, Chiba
Novo Nordisk Investigational Site, Fukuoka-shi, Fukuoka
Novo Nordisk Investigational Site, Hamamatsu-shi, Shizuoka
Novo Nordisk Investigational Site, Itabashi-ku, Tokyo
Novo Nordisk Investigational Site, Kagoshima
Novo Nordisk Investigational Site, Kyoto-shi Kyoto
Novo Nordisk Investigational Site, Minato-ku, Tokyo
Novo Nordisk Investigational Site, Okayama, Okayama
Novo Nordisk Investigational Site, Sagamihara-shi, Kanagawa
Novo Nordisk Investigational Site, Sapporo, Hokkaido
Novo Nordisk Investigational Site, Sappro-shi, Hokkaido
Novo Nordisk Investigational Site, Tokyo
Novo Nordisk Investigational Site, Yamagata-shi, Yamagata
Novo Nordisk Investigational Site, Yokohama, Kanagawa
Novo Nordisk Investigational Site, Riga
Novo Nordisk Investigational Site, Vilnius
Novo Nordisk Investigational Site, Oslo
Novo Nordisk Investigational Site, Bialystok
Novo Nordisk Investigational Site, Gdansk
Novo Nordisk Investigational Site, Krakow
Novo Nordisk Investigational Site, Warsaw
Novo Nordisk Investigational Site, Warsaw
Novo Nordisk Investigational Site, Wroclaw
Novo Nordisk Investigational Site, Wroclaw
Novo Nordisk Investigational Site, Bucharest
Novo Nordisk Investigational Site, Pretoria
Novo Nordisk Investigational Site, Gothenburg
Novo Nordisk Investigational Site, Stockholm
Novo Nordisk Investigational Site, Uppsala
Novo Nordisk Investigational Site, Adana
Novo Nordisk Investigational Site, Kiev
Novo Nordisk Investigational Site, Kyiv
Novo Nordisk Investigational Site, Birmingham
Novo Nordisk Investigational Site, Coventry
Novo Nordisk Investigational Site, Exeter
Novo Nordisk Investigational Site, Hull
Novo Nordisk Investigational Site, Leeds
Novo Nordisk Investigational Site, London
Novo Nordisk Investigational Site, London
Novo Nordisk Investigational Site, Manchester
Lead Sponsor
Novo Nordisk A/S
INDUSTRY